Cargando…
Process mapping strategies to prevent subcutaneous implantable cardioverter‐defibrillator infections
BACKGROUND: Infection remains a major complication of cardiac implantable electronic devices and can lead to significant morbidity and mortality. Implantable devices that avoid transvenous leads, such as the subcutaneous implantable cardioverter‐defibrillator (S‐ICD), can reduce the risk of serious...
Autores principales: | Weiss, Raul, Mark, George E., El‐Chami, Mikhael F., Biffi, Mauro, Probst, Vincent, Lambiase, Pier D., Miller, Marc A., McClernon, Timothy, Hansen, Linda K., Knight, Bradley P., Baddour, Larry M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544305/ https://www.ncbi.nlm.nih.gov/pubmed/35662315 http://dx.doi.org/10.1111/jce.15566 |
Ejemplares similares
-
Diagnosis and management of subcutaneous implantable cardioverter‐defibrillator infections based on process mapping
por: Baddour, Larry M., et al.
Publicado: (2020) -
The subcutaneous implantable cardioverter defibrillator––review of the recent data
por: Westerman, Stacy B, et al.
Publicado: (2018) -
Subcutaneous implantable cardioverter-defibrillator implantation in a patient with bilateral pectoral deep brain stimulators
por: Tejada, Thor, et al.
Publicado: (2017) -
Atrial pacing–induced oversensing in subcutaneous implantable cardioverter-defibrillator
por: Wharmby, Amy, et al.
Publicado: (2023) -
Successful defibrillation verification in subcutaneous implantable cardioverter‐defibrillator recipients by low‐energy shocks
por: Biffi, Mauro, et al.
Publicado: (2019)